Quality assessment of meta-analyses of RCTs of pharmacotherapy in major depressive disorder

References

• Glass G. Primary, secondary, and meta-analysis of research. Education Research 1976;5:3–8
   Google Scholar
• Cook D, Sackett D, Spitzer W. Methodologic guidelines for systematic reviews of randomized controlled trials in health care from the Potsdam consultation on meta-analysis. Journal of Clinical Epidemiology 1995;48:167–71
   Google Scholar
• Bero L, Rennie D. The Cochrane Collaboration: preparing, maintaining, and disseminating systematic reviews of the effects of health care. Journal of the American Medical Association 1995;274:1935–8
   PubMed Web of Science ®Google Scholar
• Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999;354:1896–900
   PubMed Web of Science ®Google Scholar
• Moher D, Cook DJ, Eastwood S, Olkin I, Drummond R, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUORUM statement. British Journal of Surgery 2000;87: 1448–54
   PubMed Web of Science ®Google Scholar
• Chalmers I, Haynes R. Reporting, updating, and correcting systematic reviews of the effects of health care. In: Chalmers I, Altman D, editors. Systematic reviews, London: BMJ Publishing Group, 1995. p 86–95.
   Google Scholar
• Hamilton M. A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 1960;23:56–62
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979;134:382–9
   PubMed Web of Science ®Google Scholar
• Fleiss J. Measuring nominal scale agreement among many raters. Psychological Bulletin 1971;76:378–82
   Web of Science ®Google Scholar
• Fleiss J, Nee J, Landis J. The large sample variance of kappa in the case of different sets of raters. Psychological Bulletin 1979;86:974–7
   Google Scholar
• Squires B. Abstracts: the need for improvement. Canadian Medical Association Journal 1991;144:421
   Web of Science ®Google Scholar
• Narine L, Yee S, Einarson T, Ilersich A. Quality of abstracts of original research articles in Canadian Medical Association Journal in 1989. Canadian Medical Association Journal 1991;144:449–53
   PubMed Web of Science ®Google Scholar
• Squires B. Evaluating structure abstracts. Canadian Medical Association Journal 1994;150:1535
   Google Scholar
• Taddio A, Pain T, Fassos F, Boon H, Ilersich A, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal, and the Journal of the American Medical Association. Canadian Medical Association Journal 1994;150:1611–5
   Web of Science ®Google Scholar
• Mulrow C, Thacker S, Pugh J. A proposal for more informative abstracts of review articles. Annals of Internal Medicine 1988;108:613–5
   PubMed Web of Science ®Google Scholar
• Den Boer J, Watts G. The choice of treatment in severe depression. The severe depression meta analysis. Primary Care Psychiatry 1999;5:S21–S24
   Google Scholar
• Srisurapanont M., Boonyanaruthee V. Alprazolam and standard antidepressants in the treatment of depression: a meta-analysis of the antidepressant effect. Journal of the Medical Association of Thailand 1997;80:183–8
   PubMedGoogle Scholar
• Souza FG, Goodwin GM. Lithium treatment and prophylaxi in unipolar depression: a meta-analysis. British Journal of Psychiatry 1991;158:666–75
   PubMed Web of Science ®Google Scholar
• Guelfi JD. Efficacy of tianeptine in comparative trials versus reference antidepressants. An overview. British Journal of Psychiatry 1992;160\(Suppl. 15):72–75
   Google Scholar
• Tignol J, Stoker MJ, Dunbar JC. Paroxetine in treatment of melancholia and severe depression. International Clinical Psychopharmacology 1992;7:91–4
   PubMed Web of Science ®Google Scholar
• Veiel HOF. A preliminary profile of neuropsychological deficits associated with major depression. Journal of Clinical and Experimental Neuropsychology 1997;19: 587–603
   PubMed Web of Science ®Google Scholar
• Fawcett J, Marcus RN, Anton SF, O’Brien K, Schwiderski U. Response of anxiety and agitation symptoms during nefazodone treatment of major depression. Journal of Clinical Psychiatry 1995;56\(Suppl. 6):37–42
   Google Scholar
• Thase M, Trivedi MH, Rush JA. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 2001; 12:185–219
   Google Scholar
• Westen D, Morrison K. A multidimensional meta-analysis of treatments for depression, panic and generalized anxiety disorder: an empirical examination of the status of empirically supported therapies. Journal of Consulting and Clinical Psychology 2001;69:875–99
   PubMed Web of Science ®Google Scholar
• Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhamme W, Melchart D. St John’s wort for depression – an overview and meta-analysis of randomised clinical trials. British Medical Journal 1996;313:253–8
   PubMed Web of Science ®Google Scholar
• Bressa GM. S-adenosyl-1-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurologica Scandinavica 1994;154(Suppl.):7–14
   Google Scholar
• DeRubeis RJ, Gelfand LA, Tang TZ, Simons AD. Medications versus cognitive behavior therapy for severely depressed outpatients: mega-analysis of four randomized comparisons. American Journal of Psychiatry 1999;156:1007–13
   PubMed Web of Science ®Google Scholar
• Petty F, Madhukar HT, Fulton M, Rush JA. Benzodiazepines as antidepressants: does GABA play a role in depression? Biological Psychiatry 1995;38:578–91
   PubMed Web of Science ®Google Scholar
• Evans MF, Morgenstern K. St. John’s wort: an herbal remedy for depression? Canadian Family Physician. 1997;43:1735–6
   PubMed Web of Science ®Google Scholar
• Hippius H. St John’s wort (Hypericum perforatum) – a herbal antidepressant. Current Medical Research and Opinion 1998;14:171–84
   PubMed Web of Science ®Google Scholar
• Gerson S, Belin T, Kaufman A, Mintz J, Jarvik L. Pharmacological and psychological treatments for depressed older patients: a meta-analysis and overview of recent findings. Harvard Review of Psychiatry 1999;7:1–28
   Google Scholar
• Kim HL, Streltzer J, Goebert D. St. John’s Wort for depression. A Meta-analysis of well-defined clinical trials. The Journal of Nervous and Mental Disease 1999;187:532–9
   Google Scholar
• Zweifel JE, O’Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22: 189–212
   PubMed Web of Science ®Google Scholar
• Kasper S, Olie JP. A meta-analysis of randomized controlled trials of tianeptine versus SSRI in the short-term treatment of depression. European Psychiatry 2002;17:331–40
   PubMed Web of Science ®Google Scholar
• Lecrubier Y, Pletan Y, Solles A, Tournoux A, Magne V. Clinical efficacy of milnacipran: placebo-control trials. International Clinical Psychopharmacology 1996;11:29–33
   Google Scholar
• Kasper S, Pletan T, Solles A, Tournoux A. Comparative studies with milnacipran and tricyclic antidepressants in treatment of patients with major depresion: a summary of clinical trial results. International Clinical Psychopharmacology 1996;11:35–9
   PubMed Web of Science ®Google Scholar
• Ribeiro MG, Pereira ELA, Santos-Jesus R, Sena EP, Petribu K, Oliveira IR. Nortriptyline blood levels and clinical outcome: meta-analysis of published studies. Revista Brasileira de Psiquiatria 2000;22:51–6
   Google Scholar
• Srisurapanont M. Response and discontinuation rats of newer antidepressants: a meta-analysis of randomized controlled trials in treating depression. Journal of the Medical Association of Thailand 1998;81:387–92
   PubMedGoogle Scholar
• Tollefson GD. Holman SL. How long to onset of antidepressant action: a meta-analysis of patients treated with fluoxetine or placebo. International Clinical Psychopharmacology 1994;9: 245–50
   PubMed Web of Science ®Google Scholar
• Thase M, Entsuah RA, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. British Journal of Psychiatry 2001;178:234–41
   Google Scholar
• Freemantle N, Anderson IM, Young P. Predictive value of pharmacological activity for the relative efficacy of antidepressant drugs. British Journal of Psychiatry 2000;177: 292–302
   Google Scholar
• Hotopf M, Hardy R, Lewis G. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. British Journal of Psychiatry 1997;170:120–7
   Google Scholar
• Beasley CM, Dornseif BE, Bosomworth JC, et al. Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. British Medical Journal 1991;303:685–92
   PubMed Web of Science ®Google Scholar
• Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. British Medical Journal 1995;310:1433–8
   PubMed Web of Science ®Google Scholar
• Beasley CM, Koke SC, Nilsson ME, Gonzales GS. Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder. Clinical Therapeutics 2000;22:1319–30
   PubMed Web of Science ®Google Scholar
• Trindade E, Menon D, Topfer L, Coloma C. Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Canadian Medical Association Journal 1998;159:1245–52
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Kasper S. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. International Clinical Psychopharmacology 1995;9\(Suppl. 4):33–40
   Google Scholar
• Gearge MS, Lydiard RB. Speed of onset of action of the newer antidepressants fluoxetine and bupropion. International Clinical Psychopharmacology 1991;6:209–17
   PubMed Web of Science ®Google Scholar
• Preskorn S, Jerkovich GS. Central nervous system toxicity of tricyclic antidepressants: phenomenology, course, risk factors, and role of therapeutic drug monitoring. Journal of Clinical Psychopharmacology 1990;10:88–95
   PubMed Web of Science ®Google Scholar
• Jonas JM, Hearron Jr, E. Alprazolam and suicidal ideation: a meta-analysis of controlled trials in the treatment of depression. Journal of Clinical Psychopharmacology 1996;16:208–11
   Google Scholar
• Entsuah AR, Huang H, Thase ME. Response and remission rates in different subpopulations with major depressive disorders administered venlafaxine, selective serotonin reuptake inhibitors or placebo. Journal of Clinical Psychiatry 2001;62:869–77
   Google Scholar
• Loonen AJ, Peer PG, Zwanikken GJ. Continuation and maintenance therapy with antidepressive agents. Meta-analysis of research. Pharmaceutisch Weekblad – Scientific Edition 1991;13:167–75
   Google Scholar
• Stassen HH, Angst J, Delini-Stula A. Severity at baseline and onset of improvement in depression: meta-analysis of imipramine and moclobemide versus placebo. European Psychiatry 1994;9:129–36
   Google Scholar
• Anderson IM, Tomenson BM. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. Journal of Psychopharmacology 1994;8:238–49
   PubMed Web of Science ®Google Scholar
• Bech P, Cialdella P. Citalopram in depression—meta-analysis of intended and unintended effects. International Clinical Psychopharmacology 1992;6:45–54
   PubMed Web of Science ®Google Scholar
• Pandre AC, Sayler ME. Severity of depression and response to fluoxetine. International Clinical Psychopharmacology 1993;8:243–5
   PubMed Web of Science ®Google Scholar
• Cole MG, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. American Journal of Psychiatry 1999;156:1182–9
   Google Scholar
• McCusker J, Cole M, Keller I, Bellevance F, Berard A. Effectiveness of treatment of depresion in older ambulatory patients. Archives of Internal Medicine 1998;158:705–12
   PubMedGoogle Scholar
• Hazell P, O’Connel D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. British Medical Journal 1995;310:897–904
   PubMed Web of Science ®Google Scholar
• Amrein R, Stabl M, Henauer S, Affolter E, Jonkanski I. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Canadian Journal of Psychiatry 1997;42:1043–50
   Google Scholar
• Joffe R, Sokolov S, Streiner D. Antidepressant treatment of depression: a meta analysis. Canadian Journal of Psychiatry 1996;41:613–6
   Google Scholar
• Angst J, Scheidegger P, Stabl M. Efficacy of moclobemide in different patient groups. Clinical Neuropharmacology 1993;16\(Suppl. 2):S55–S62
   Google Scholar
• Cole MG. The prognosis of depression in the elderly. Canadian Medical Association Journal 1990;143:633–9
   Web of Science ®Google Scholar
• Cole MG, Bellavance F. Depression in elderly medical inpatients: a meta-analysis of outcomes. Canadian Medical Association Journal 1997;157:1055–60
   Web of Science ®Google Scholar
• Chen R, Copeland JR, Wei L. A meta-analysis of epidemiological studies in depression of older people in China. International Journal of Geriatric Psychiatry 1999;14:821–30
   PubMed Web of Science ®Google Scholar
• Cole MG, Eli LM, McCusker J, Bellavance F, Mansour A. Feasibility and effectiveness of treatments for depression in elderly medical inpatients. International Psychogeriatrics 2000;12:453–61
   Google Scholar
• Gladstone TRG, Kaslow NJ. Depression and attributions in children and adolescents: a meta-analytic review. Journal of Abnormal Child Psychology 1995;23:597–604
   PubMed Web of Science ®Google Scholar
• Mittmann N, Herrmann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. Journal of Affective Disorders 1997;46:191–217
   PubMed Web of Science ®Google Scholar
• Thurber S, Ensign J, Punnett AF, Welter K. A Meta-analysis of antidepressant outcomes studies that involved children and adolescents. Journal of Clinical Psychology 1995;51:340–5
   PubMed Web of Science ®Google Scholar
• Maneeton N, Srisurapanont M. Tricyclic antidepressants for depressive disorders in children and adolescents: a meta-analysis of randomized controlled trials. Journal of the Medical Association of Thailand 2000;83:1367–74
   PubMedGoogle Scholar
• Dunbar JC. Paroxetine in the elderly: a comparative meta-analysis against standard antidepressant pharmacotherapy. Pharmacology 1995;51:137–44
   PubMed Web of Science ®Google Scholar
• Westwick F. Depression and selective serotonin reuptake inhibitors. British Journal of Hospital Medicine 1990;44:367
   PubMed Web of Science ®Google Scholar
• Bollini P, Pampallona S, Tibaldi G, Kupelnick B, Munizza C. Effectiveness of antidepressants. Meta-analysis of dose–effect relationships in randomised clinical trials. British Journal of Psychiatry 1999;174:297–303
   Google Scholar
• Hotopf M, Lewis G, Normand C. Are SSRIs cost-effective alternative to tricyclics? British Journal of Psychiatry 1996;168:404–9
   Google Scholar
• Montgomery SA, Pedersen V, Tanghøj P, Rasmussen C, Rioux P. The optimal dosing regimen for citalopram-a meta-analysis of nine placebo-controlled studies. International Clinical Psychopharmacology 1994;9\(Suppl. 1):35–40
   Google Scholar
• Greenberg RP, Greenberg MD, Bornstein RF, Fisher S. A meta-analysis of antidepressant outcome under ‘blinder’ conditions. Journal of Consulting and Clinical Psychology 1992;60:664–9
   PubMed Web of Science ®Google Scholar
• Van Weel-Baumgarten EM, Schers HJ, Van den Bosch WJ, Van den Hoogen HJ, Zitman FG. Long-term follow-up of depression among patients in the community and in family practice settings. The Journal of Family Practice 2000;49:1113–20
   Google Scholar
• Wexler BE, Cicchetti DV. The outpatient treatment of depression. Implications of outcome research for clinical practice. Journal of Nervous and Mental Disease 1992;180:277–86
   PubMed Web of Science ®Google Scholar
• Faries D, Herrera J, Rayamajhi J, DeBrota D, Demitrack M, Potter WZ. The responsiveness of the Hamilton Depression Rating Scale. Journal of Psychiatric Research 2000;34:3–10
   PubMed Web of Science ®Google Scholar
• Stassen HH, Delini-Stula A. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses. Pharmacopsychiatry 1996;29:87–96
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Prost JF, Solles A, Briley M. Efficacy and tolerability of milnacipran: an overview. International Clinical Psychopharmacology 1996;11:47–51
   PubMed Web of Science ®Google Scholar
• Angst J, Amrein R, Stabl M. Moclobemide and tricyclic antidepressants in severe depression: meta-analysis and prospective studies. Journal of Clinical Psychopharmacology 1995;15\(Suppl. 2):16S–23S
   Google Scholar